ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.

Yan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.